IL33 and immunoglobulin G4-related sclerosing disease: Although most IL33/ST2 studies rely on isolated organ systems (e.g., pulmonary fibrosis models), further clinical research is needed to clarify whether this axis is the core driver of Th2‐mediated fibrosis in IgG4‐RD.